Literature DB >> 24239111

Induction of epithelial-to-mesenchymal transition in proximal tubular epithelial cells on microfluidic devices.

Mengying Zhou1, Huipeng Ma2, Hongli Lin3, Jianhua Qin4.   

Abstract

In proteinuric nephropathy, epithelial-to-mesenchymal transition (EMT) is an important mechanism that causes renal interstitial fibrosis. The precise role of EMT in the pathogenesis of fibrosis remains controversial, partly due to the absence of suitable in vitro or in vivo models. We developed two microfluidic and compartmental chips that reproduced the fluidic and three-dimensional microenvironment of proximal tubular epithelial cells in vivo. Using one microfluidic device, we stimulated epithelial cells with a flow of healthy human serum, heat-inactivated serum and complement C3a, which mimicked the flow of urine within the proximal tubule. We observed that epithelial cells exposed to serum proteins became apoptotic or developed a mesenchymal phenotype. Incubating cells with C3a induced similar features. However, cells exposed to heat-inactivated serum did not adopt the mesenchymal phenotype. Furthermore, we successfully recorded the cellular morphological changes and the process of transmigration into basement membrane extract during EMT in real-time using another three-dimensional microdevice. In conclusion, we have established a cell-culture system that mimics the native microenvironment of the proximal tubule to a certain extent. Our data indicates that EMT did occur in epithelial cells that were exposed to serum proteins, and C3a plays an essential role in this pathological process.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Biomimetic of proximal tubule; C3a; Epithelial-to-mesenchymal transition; Microfluidic; Migration

Mesh:

Substances:

Year:  2013        PMID: 24239111     DOI: 10.1016/j.biomaterials.2013.10.070

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  15 in total

Review 1.  Complement activation in progressive renal disease.

Authors:  Amy Fearn; Neil Stephen Sheerin
Journal:  World J Nephrol       Date:  2015-02-06

2.  Microfluidic organs-on-chips.

Authors:  Sangeeta N Bhatia; Donald E Ingber
Journal:  Nat Biotechnol       Date:  2014-08       Impact factor: 54.908

3.  A Role for 3D Printing in Kidney-on-a-Chip Platforms.

Authors:  Ryan D Sochol; Navin R Gupta; Joseph V Bonventre
Journal:  Curr Transplant Rep       Date:  2016-01-20

Review 4.  Nanomedicines for renal disease: current status and future applications.

Authors:  Nazila Kamaly; John C He; Dennis A Ausiello; Omid C Farokhzad
Journal:  Nat Rev Nephrol       Date:  2016-10-31       Impact factor: 28.314

Review 5.  The role of the complement system in cancer.

Authors:  Vahid Afshar-Kharghan
Journal:  J Clin Invest       Date:  2017-03-01       Impact factor: 14.808

6.  Functional Drug Screening using Kidney Cells On-A-Chip: Advances in Disease Modeling and Development of Biomarkers.

Authors:  Amrendra K Ajay
Journal:  Kidney360       Date:  2022-02-24

7.  The potential role of complement alternative pathway activation in hypertensive renal damage.

Authors:  Chongjian Wang; Zhiyu Wang; Wen Zhang
Journal:  Exp Biol Med (Maywood)       Date:  2022-04-27

8.  Development of a Functional Glomerulus at the Organ Level on a Chip to Mimic Hypertensive Nephropathy.

Authors:  Mengying Zhou; Xulang Zhang; Xinyu Wen; Taihua Wu; Weidong Wang; Mingzhou Yang; Jing Wang; Ming Fang; Bingcheng Lin; Hongli Lin
Journal:  Sci Rep       Date:  2016-08-25       Impact factor: 4.379

Review 9.  Engineering and monitoring cellular barrier models.

Authors:  Jose Yeste; Xavi Illa; Mar Alvarez; Rosa Villa
Journal:  J Biol Eng       Date:  2018-09-12       Impact factor: 4.355

Review 10.  Modeling Barrier Tissues In Vitro: Methods, Achievements, and Challenges.

Authors:  Courtney M Sakolish; Mandy B Esch; James J Hickman; Michael L Shuler; Gretchen J Mahler
Journal:  EBioMedicine       Date:  2016-02-13       Impact factor: 8.143

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.